Deep learning has great potential in medical imaging. 168 patients underwent 3T mpMRI of prostate before mpMR-targeted biopsies plus systematic sampling. Two radiologists from two separate institutions, by using the Prostate Imaging Reporting and Data System (PI-RADS) V2 and a multimodal convolutional neural networks (CNN)-based deep learning, independently assessed prostate MRI examinations. Histopathologic findings were used as the reference standard. In detecting csPCa, both reviewers had significantly higher AUCs using CNN-based deep learning. Reviewer 2 benefited much more from CNN-based deep learning than did reviewer 1. Combined PI-RADS with CNN-based deep learning contribute significant incremental value in the detection of csPCa.
mpMRI is generally considered the most accurate imaging method for csPCa [1] . Futterer et al. [2] conducted conducted a systematic review of the literature of 12 studies from January 1, 2000 to September 30, 2014, the findings showed that mpMRI had a sensitivity of 58–96% and specificity of 23–87% in detection of csPCa.
The role of mpMRI in prostate cancer management has been changing with the development of techniques such as deep learning, which is part of a broader family of artificial intelligence and machine learning [3,4]. Several studies have been successfully conducted to explore the ability of CNN-based deep learning and achieved remarkable results for various medical applications, such as thoraco-abdominal lymph node detection in computed tomography (CT) scans, interstitial lung disease classification in CT scans, (39)polyp detection in colonoscopy videos,pulmonary nodule detection in CT images(41).The use of a deep learning simplifies workflow, enhances productivity. Improvements in patient care include shorter reading time, shorter hospital stays, decreased report-waiting times, faster diagnoses, decreased inter-/intra-observer variations.
Our study showed that in the detection of csPCa, radiologists performed substantially better using mbined PI-RADS V2 with CNN-based deep learning than with PI-RADS V2 alone. CNN-based deep learning is particularly helpful in patients with PIRADS 3 (the presence of csPCa is equivocal), CNN-based deep learning changed the csPCa judgment in 16 of 17 patients (94%) for Reviewer 1 and in 76 of 77 patients (99%) for Reviewer 2; in 13 of these 16 patients (81%) for Reviewer 1 and in 67of 76 patients (88%) for Reviewer 2, the changes were appropriate.
[1] Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM et al: PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. European urology 2016, 69(1):16-40.
[2] Venderink W, van Luijtelaar A, Bomers JG, van der Leest M, Hulsbergen-van de Kaa C, Barentsz JO, Sedelaar JP, Futterer JJ: Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer. European urology 2017
[3] Fehr D, Veeraraghavan H, Wibmer A, Gondo T, Matsumoto K, Vargas HA, Sala E, Hricak H, Deasy JO: Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America 2015, 112(46):E6265-6273.
[4] Peng Y, Jiang Y, Yang C, Brown JB, Antic T, Sethi I, Schmid-Tannwald C, Giger ML, Eggener SE, Oto A: Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Radiology 2013, 267(3):787-796.